JP2005513054A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005513054A5 JP2005513054A5 JP2003552118A JP2003552118A JP2005513054A5 JP 2005513054 A5 JP2005513054 A5 JP 2005513054A5 JP 2003552118 A JP2003552118 A JP 2003552118A JP 2003552118 A JP2003552118 A JP 2003552118A JP 2005513054 A5 JP2005513054 A5 JP 2005513054A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- nucleic acid
- amino acid
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 57
- 108090000765 processed proteins & peptides Proteins 0.000 claims 57
- 229920001184 polypeptide Polymers 0.000 claims 56
- 150000001875 compounds Chemical class 0.000 claims 33
- 102000039446 nucleic acids Human genes 0.000 claims 23
- 108020004707 nucleic acids Proteins 0.000 claims 23
- 150000007523 nucleic acids Chemical class 0.000 claims 23
- 239000002773 nucleotide Substances 0.000 claims 23
- 125000003729 nucleotide group Chemical group 0.000 claims 23
- 125000003275 alpha amino acid group Chemical group 0.000 claims 22
- 230000000694 effects Effects 0.000 claims 17
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 16
- 208000019838 Blood disease Diseases 0.000 claims 12
- 102000015433 Prostaglandin Receptors Human genes 0.000 claims 12
- 108010050183 Prostaglandin Receptors Proteins 0.000 claims 12
- 208000014951 hematologic disease Diseases 0.000 claims 12
- 208000018706 hematopoietic system disease Diseases 0.000 claims 12
- 238000000034 method Methods 0.000 claims 11
- 230000011132 hemopoiesis Effects 0.000 claims 6
- 210000000130 stem cell Anatomy 0.000 claims 6
- 208000031220 Hemophilia Diseases 0.000 claims 3
- 208000009292 Hemophilia A Diseases 0.000 claims 3
- 208000002903 Thalassemia Diseases 0.000 claims 3
- 208000007502 anemia Diseases 0.000 claims 3
- 230000002062 proliferating effect Effects 0.000 claims 3
- 230000003321 amplification Effects 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34160601P | 2001-12-17 | 2001-12-17 | |
| PCT/US2002/040194 WO2003051180A2 (en) | 2001-12-17 | 2002-12-17 | METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005513054A JP2005513054A (ja) | 2005-05-12 |
| JP2005513054A5 true JP2005513054A5 (enExample) | 2006-01-26 |
Family
ID=23338250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003552118A Pending JP2005513054A (ja) | 2001-12-17 | 2002-12-17 | ２５２、３０４、１９８０、１４７１７、９９４１、１９３１０、および１７８３２を用いて血液障害を処置するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20030134314A1 (enExample) |
| EP (1) | EP1455580A4 (enExample) |
| JP (1) | JP2005513054A (enExample) |
| AU (1) | AU2002361711A1 (enExample) |
| WO (1) | WO2003051180A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL157772A (en) * | 2003-09-04 | 2016-06-30 | Bmr Solutions Ltd | Compounds containing oligopeptide derived from turtle larvae and their use to encourage mammalian hemophysis |
| US20110092428A1 (en) * | 2007-07-02 | 2011-04-21 | The United States of America,as represented by the Secretary ,Department of Healthyand Human Service | Detecting and controlling abnormal hematopoiesis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605814A (en) * | 1993-08-31 | 1997-02-25 | Merck Frosst Canada Inc. | DNA encoding human prostaglandin receptor EP2 |
| CA2179208C (en) * | 1993-12-23 | 2003-05-27 | Rajender Kamboj | Human cns receptor polynucleotides |
| US6670149B1 (en) * | 1999-03-01 | 2003-12-30 | Millennium Pharmaceuticals, Inc. | TWIK-5 potassium channel nucleic acids and uses therefor |
| WO2001059082A1 (en) * | 2000-02-10 | 2001-08-16 | Millennium Pharmaceuticals, Inc. | 27802, an adenylate kinase |
-
2002
- 2002-12-16 US US10/320,351 patent/US20030134314A1/en not_active Abandoned
- 2002-12-17 AU AU2002361711A patent/AU2002361711A1/en not_active Abandoned
- 2002-12-17 EP EP02797349A patent/EP1455580A4/en not_active Withdrawn
- 2002-12-17 JP JP2003552118A patent/JP2005513054A/ja active Pending
- 2002-12-17 WO PCT/US2002/040194 patent/WO2003051180A2/en not_active Ceased